MedTrace Logo

Effectiveness of Astym Treatment For de Quervain's Tenosynovitis

NCT02442622 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2020-10-09

Study results available
· View outcomes & findings →

Summary

To determine if the addition of Astym treatment to traditional therapy produces a more positive outcome then traditional therapy alone for the treatment of de Quervain's tenosynvitis. Two groups will be examined with one group receiving traditional therapy and the other group receiving traditional therapy in addition to Astym treatment protocol.

Conditions

  • de Quervain's Disease

Interventions

OTHER

Occupational therapy

Occupational therapy for de Quervain's Tenosynovitis

DEVICE

Occupational therapy with ASTYM

Occupational therapy for de Quervain's Tenosynovitis plus ASTYM

Sponsors & Collaborators

Principal Investigators

  • Stephen VanLew, PhD, OTR/L · NYU Langone Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2019-04-29
Completion
2019-04-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02442622 on ClinicalTrials.gov